Keytruda And Small Cell Lung Cancer

Keytruda may be used with the chemotherapy medicines pemetrexed and a platinum as your first treatment when your lung cancer has spread advanced nsclc and is a type called nonsquamous and your tumor does not have an abnormal egfr or alk gene.

Keytruda and small cell lung cancer. Findings of the phase 1b keynote 028 trial were published in the journal of clinical oncology. Keytruda is a prescription medicine used to treat a kind of lung cancer called non small cell lung cancer nsclc. On june 17 2019 the food and drug administration granted accelerated approval to pembrolizumab keytruda merck for patients with metastatic small cell lung cancer sclc with disease. The supplemental biologics license application based on results from the phase 1b keynote 028 trial nct02054806 and the ongoing keynote 158 phase 2.

The immunotherapy agent keytruda pembrolizumab had an overall response rate orr of 33 percent in a recent trial including patients with extensive stage small cell lung cancer sclc.